Chronic Lymphocytic Leukemia Fish Probe Kit
OVQ is the FDA product code for Chronic Lymphocytic Leukemia Fish Probe Kit, a class II device type, regulated under 21 CFR 866.6040. FDA's definition for this code reads: "The CLL FISH Probe Kit is intended to detect deletion of the LSI TP53, LSI ATM, and LSI D13S319 probe targets and gain of the D12Z3 sequence in peripheral blood specimens from untreated patients with B-cell chronic lymphocytic leukemia (CLL). The assay may be used to dichotomize CLL (the 13q-, +12, or normal genotype...". As of , FDA records hold 2 510(k) clearances under this code, the most recent dated , and one recall.
Classification record
- Product code
- OVQ
- Device name
- Chronic Lymphocytic Leukemia Fish Probe Kit
- FDA definition
- The CLL FISH Probe Kit is intended to detect deletion of the LSI TP53, LSI ATM, and LSI D13S319 probe targets and gain of the D12Z3 sequence in peripheral blood specimens from untreated patients with B-cell chronic lymphocytic leukemia (CLL). The assay may be used to dichotomize CLL (the 13q-, +12, or normal genotype group versus the 11q- or 17p- group) and may be used as an aid in determining disease prognosis in combination with additional biomarkers, morphology and other clinical information.
- Regulation
- 21 CFR 866.6040
- Device class
- Class II
- Review panel
- Immunology
- Submission type
- 510(k)
- Implant
- No
- Life sustaining or supporting
- No
- GMP exempt
- No
- Third party review eligible
- Yes
- Ingested clearances
- 2
- Ingested recalls
- 1
Clearances, product code OVQ
By decision yearShow the numbers
| Year | Clearances |
|---|---|
| 1997 | 1 |
| 2011 | 1 |
Applicants with the most clearances
Product code OVQ| Applicant | Clearances |
|---|---|
| Abbott Molecular, Inc. | 1 |
| Vysis | 1 |
Companies listing this code with FDA
Companies whose registered establishments list this codeFIRST ARTICLE / WEEKLY
What cleared, what was recalled, and what changed in the standards. One edition a week for the people who make medical devices.
